Clinical Trial Update: An Observational Study of Peginterferon Alfa-2a (PEGASYS®) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B

View source ↗

Summary

This clinical trial update reports results from an observational study of peginterferon alfa-2a (PEGASYS) in patients with chronic hepatitis B, including both H…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis B, Chronic | Status: COMPLETED | Results posted: 2015-12-07